J Korean Geriatr Soc.  2008 Jun;12(2):95-101.

Clinical Features and Prognosis of Patients Who Started Hemodialysis Treatment over 60 Years Old

Affiliations
  • 1Department of Internal Medicine, National Medical Center, Seoul, Korea. shkim0@naver.com

Abstract

BACKGROUND: Observation on the hemodialysis treatment; whether there are any different effects on mortality rate, side effects, or effectiveness of the treatment depending on patients' age.
METHODS
Chronic renal failure patients who started hemodialysis treatment between 2002 and 2003 were separated in two groups, 33 patients of 60 and older and 76 patients under 60. We investigated mortality rate difference, A-V shunt re-operation, and total protein and albumin level. Also, comparing and analyzing the urea reduction ratio, we examined whether effectiveness is different depending on the patients' age.
RESULTS
The 3 year survivor rate of patients who initially started hemodialysis treatment over 60 was 66.7%, and that of the patients under 60 resulted as 73.1%. The average total protein lefel for over 60 was 6.48g/dL and for under 60 was 6.80g/dL, and albumin for over 60 was 3.15g/dL and under 60 was 3.46g/dL. We identified that the patients who repeated shunt operation in over 60 group was 4(12%) and in under 60 group was 4(5.2%). Effectiveness of the treatment, Urea Reduction Ratio(URR), for both groups was 71%.
CONCLUSION
The 3 year survivor rate of patients who initially started hemodialysis treatment over 60 was lower than the control group, but considering the remaining life expectancy, it seems to be no significant difference between the groups; and the treatment effectiveness was same in both groups.

Keyword

Hemodialysis; Over 60 years old; 3 year survival

MeSH Terms

Humans
Kidney Failure, Chronic
Life Expectancy
Prognosis
Renal Dialysis
Survivors
Treatment Outcome
Urea
Urea
Full Text Links
  • JKGS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr